Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuya Ishige

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|June 25, 2026
Identification and functional characterization of an mRNA Cap3 methyltransferase from Acanthamoeba castellanii medusavirusTokiaki Takemura, Kazuya Ishige
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
Polyphosphate kinase (PPK2), a potent, polyphosphate-driven generator of GTPKazuya Ishige, Haiyu Zhang, Arthur Kornberg
Biochemistry and Biophysics Reports|July 22, 2022
5'-CMP and 5'-UMP promote myogenic differentiation and mitochondrial biogenesis by activating myogenin and PGC-1α in a mouse myoblast C2C12 cell lineKosuke Nakagawara, Chieri Takeuchi, Kazuya Ishige
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2002
A polyphosphate kinase (PPK2) widely conserved in bacteriaHaiyu Zhang, Kazuya Ishige, Arthur Kornberg
Biochemistry and Biophysics Reports|April 6, 2023
5'-CMP and 5'-UMP alleviate dexamethasone-induced muscular atrophy in C2C12 myotubesKosuke Nakagawara, Chieri Takeuchi, Kazuya Ishige
Frontiers in Sports and Active Living|July 30, 2024
5'-UMP inhibited muscle atrophy due to detraining: a randomized, double-blinded, placebo-controlled, parallel-group comparative studyMika Inoue, Atsushi Kubota, Yuji Takazawa, et al.
Molecular Therapy. Methods & Clinical Development|January 9, 2023
Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primatesShokichi Takahama, Kazuya Ishige, Takuto Nogimori, et al.
Glycoconjugate Journal|May 15, 2010
Preparation of chondroitin sulfate libraries containing disulfated disaccharide units and inhibition of thrombin by these chondroitin sulfatesMario Numakura, Noriko Kusakabe, Kazuya Ishige, et al.
Journal of Hypertension|August 24, 2017
Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodentsTatsuhiko Azegami, Yoshikazu Yuki, Kaori Hayashi, et al.
Science Translational Medicine|November 12, 2025
Cationic nanogel-based nasal therapeutic HPV vaccine prevents the development of cervical cancerRika Nakahashi-Ouchida, Hiromi Mori, Yoshikazu Yuki, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|June 25, 2026
Identification and functional characterization of an mRNA Cap3 methyltransferase from Acanthamoeba castellanii medusavirusTokiaki Takemura, Kazuya Ishige
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
Polyphosphate kinase (PPK2), a potent, polyphosphate-driven generator of GTPKazuya Ishige, Haiyu Zhang, Arthur Kornberg
Biochemistry and Biophysics Reports|July 22, 2022
5'-CMP and 5'-UMP promote myogenic differentiation and mitochondrial biogenesis by activating myogenin and PGC-1α in a mouse myoblast C2C12 cell lineKosuke Nakagawara, Chieri Takeuchi, Kazuya Ishige
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2002
A polyphosphate kinase (PPK2) widely conserved in bacteriaHaiyu Zhang, Kazuya Ishige, Arthur Kornberg
Biochemistry and Biophysics Reports|April 6, 2023
5'-CMP and 5'-UMP alleviate dexamethasone-induced muscular atrophy in C2C12 myotubesKosuke Nakagawara, Chieri Takeuchi, Kazuya Ishige
Frontiers in Sports and Active Living|July 30, 2024
5'-UMP inhibited muscle atrophy due to detraining: a randomized, double-blinded, placebo-controlled, parallel-group comparative studyMika Inoue, Atsushi Kubota, Yuji Takazawa, et al.
Molecular Therapy. Methods & Clinical Development|January 9, 2023
Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primatesShokichi Takahama, Kazuya Ishige, Takuto Nogimori, et al.
Glycoconjugate Journal|May 15, 2010
Preparation of chondroitin sulfate libraries containing disulfated disaccharide units and inhibition of thrombin by these chondroitin sulfatesMario Numakura, Noriko Kusakabe, Kazuya Ishige, et al.
Journal of Hypertension|August 24, 2017
Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodentsTatsuhiko Azegami, Yoshikazu Yuki, Kaori Hayashi, et al.
Science Translational Medicine|November 12, 2025
Cationic nanogel-based nasal therapeutic HPV vaccine prevents the development of cervical cancerRika Nakahashi-Ouchida, Hiromi Mori, Yoshikazu Yuki, et al.
Pageof 2